It may also avoid the injection supplies and technique involved with weekly injectable medicines
Additionally, given the lack of research available, its unclear whether it has any additional benefits over regular diet and exercise
The medication itself is not on deferral lists, but your overall health, hydration, and the stability of any underlying conditions are the deciding factors
The STEP 1 trial, published in the New England Journal of Medicine, showed that participants taking 2.4mg of semaglutide lost an average of 14.9% of their body weight over 68 weeks, significantly more than the placebo group
As a triple GLP-1/GIP/glucagon receptor agonist, it adds glucagon receptor activation on top of the dual mechanisms that tirzepatide already provides